시장조사 보고서 : 세계의 유전성 암 검사 시장예측 2021년-2026년

■ 영문 제목 : Global Hereditary Cancer Testing Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K00125 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 113 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 유전성 암 검사의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (RNA 검사, DNA 검사)와 용도별 시장규모 (유방암, 위장암, 전립선암, 호흡기암, 폐암, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 유전성 암 검사 시장 점유율
- 지역별 유전성 암 검사 시장규모
- 주요지역의 종류별 시장규모 (RNA 검사, DNA 검사)
- 주요지역의 용도별 시장규모 (유방암, 위장암, 전립선암, 호흡기암, 폐암, 기타)
- 미주의 유전성 암 검사 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 유전성 암 검사 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 유전성 암 검사 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 유전성 암 검사 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 유전성 암 검사 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Ambry Genetics (Konica Minota), Asper Biogene, Natera, Caris Life Sciences, BioReference Laboratories (GeneDx), LabSolutions, Progenity，Inc, ARUP Laboratories, Myriad, NeoGenomics, Blueprint Genetics, CellMax Life, Fulgent Genetics, Strand Life Sciences, Myogenes, LabCorp, Quest Diagnostics, Pathway Genomics
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Hereditary Cancer Testing will have significant change from previous year. By the most conservative estimates of global Hereditary Cancer Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Hereditary Cancer Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Hereditary Cancer Testing market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
RNA Testing
DNA Testing

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Ambry Genetics (Konica Minota)
Asper Biogene
Natera
Caris Life Sciences
BioReference Laboratories (GeneDx)
LabSolutions
Progenity，Inc
ARUP Laboratories
Myriad
NeoGenomics
Blueprint Genetics
CellMax Life
Fulgent Genetics
Strand Life Sciences
Myogenes
LabCorp
Quest Diagnostics
Pathway Genomics

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hereditary Cancer Testing Market Size 2016-2026
2.1.2 Hereditary Cancer Testing Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Hereditary Cancer Testing Segment by Type
2.2.1 RNA Testing
2.2.2 RNA Testing
2.3 Hereditary Cancer Testing Market Size by Type
2.3.1 Global Hereditary Cancer Testing Market Size CAGR by Type
2.3.2 Global Hereditary Cancer Testing Market Size Market Share by Type (2016-2021)
2.4 Hereditary Cancer Testing Segment by Application
2.4.1 Breast Cancer
2.4.2 Gastrointestinal Cancer
2.4.3 Prostate Cancer
2.4.4 Respiratory/Lung Cancer
2.4.5 Other Cancers
2.5 Hereditary Cancer Testing Market Size by Application
2.5.1 Global Hereditary Cancer Testing Market Size CAGR by Application
2.5.2 Global Hereditary Cancer Testing Market Size Market Share by Application (2016-2021)

3 Hereditary Cancer Testing Market Size by Players
3.1 Hereditary Cancer Testing Market Size Market Share by Players
3.1.1 Global Hereditary Cancer Testing Revenue by Players (2019-2021E)
3.1.2 Global Hereditary Cancer Testing Revenue Market Share by Players (2019-2021E)
3.2 Global Hereditary Cancer Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Hereditary Cancer Testing by Regions
4.1 Hereditary Cancer Testing Market Size by Regions (2016-2021)
4.2 Americas Hereditary Cancer Testing Market Size Growth (2016-2021)
4.3 APAC Hereditary Cancer Testing Market Size Growth (2016-2021)
4.4 Europe Hereditary Cancer Testing Market Size Growth (2016-2021)
4.5 Middle East & Africa Hereditary Cancer Testing Market Size Growth (2016-2021)

5 Americas
5.1 Americas Hereditary Cancer Testing Market Size by Country (2016-2021)
5.2 Americas Hereditary Cancer Testing Market Size by Type (2016-2021)
5.3 Americas Hereditary Cancer Testing Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Hereditary Cancer Testing Market Size by Region (2016-2021)
6.2 APAC Hereditary Cancer Testing Market Size by Type (2016-2021)
6.3 APAC Hereditary Cancer Testing Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Hereditary Cancer Testing by Country (2016-2021)
7.2 Europe Hereditary Cancer Testing Market Size by Type (2016-2021)
7.3 Europe Hereditary Cancer Testing Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Hereditary Cancer Testing by Region (2016-2021)
8.2 Middle East & Africa Hereditary Cancer Testing Market Size by Type (2016-2021)
8.3 Middle East & Africa Hereditary Cancer Testing Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Hereditary Cancer Testing Market Forecast
10.1 Global Hereditary Cancer Testing Forecast by Regions (2021-2026)
10.1.1 Global Hereditary Cancer Testing Forecast by Regions (2021-2026)
10.1.2 Americas Hereditary Cancer Testing Forecast
10.1.3 APAC Hereditary Cancer Testing Forecast
10.1.4 Europe Hereditary Cancer Testing Forecast
10.1.5 Middle East & Africa Hereditary Cancer Testing Forecast
10.2 Americas Hereditary Cancer Testing Forecast by Countries (2021-2026)
10.2.1 United States Hereditary Cancer Testing Market Forecast
10.2.2 Canada Hereditary Cancer Testing Market Forecast
10.2.3 Mexico Hereditary Cancer Testing Market Forecast
10.2.4 Brazil Hereditary Cancer Testing Market Forecast
10.3 APAC Hereditary Cancer Testing Forecast by Region (2021-2026)
10.3.1 China Hereditary Cancer Testing Market Forecast
10.3.2 Japan Hereditary Cancer Testing Market Forecast
10.3.3 Korea Hereditary Cancer Testing Market Forecast
10.3.4 Southeast Asia Hereditary Cancer Testing Market Forecast
10.3.5 India Hereditary Cancer Testing Market Forecast
10.3.6 Australia Hereditary Cancer Testing Market Forecast
10.4 Europe Hereditary Cancer Testing Forecast by Country (2021-2026)
10.4.1 Germany Hereditary Cancer Testing Market Forecast
10.4.2 France Hereditary Cancer Testing Market Forecast
10.4.3 UK Hereditary Cancer Testing Market Forecast
10.4.4 Italy Hereditary Cancer Testing Market Forecast
10.4.5 Russia Hereditary Cancer Testing Market Forecast
10.5 Middle East & Africa Hereditary Cancer Testing Forecast by Region (2021-2026)
10.5.1 Egypt Hereditary Cancer Testing Market Forecast
10.5.2 South Africa Hereditary Cancer Testing Market Forecast
10.5.3 Israel Hereditary Cancer Testing Market Forecast
10.5.4 Turkey Hereditary Cancer Testing Market Forecast
10.5.5 GCC Countries Hereditary Cancer Testing Market Forecast
10.6 Global Hereditary Cancer Testing Forecast by Type (2021-2026)
10.7 Global Hereditary Cancer Testing Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Ambry Genetics (Konica Minota)
11.1.1 Ambry Genetics (Konica Minota) Company Information
11.1.2 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Product Offered
11.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Ambry Genetics (Konica Minota) Main Business Overview
11.1.5 Ambry Genetics (Konica Minota) Latest Developments
11.2 Asper Biogene
11.2.1 Asper Biogene Company Information
11.2.2 Asper Biogene Hereditary Cancer Testing Product Offered
11.2.3 Asper Biogene Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Asper Biogene Main Business Overview
11.2.5 Asper Biogene Latest Developments
11.3 Natera
11.3.1 Natera Company Information
11.3.2 Natera Hereditary Cancer Testing Product Offered
11.3.3 Natera Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Natera Main Business Overview
11.3.5 Natera Latest Developments
11.4 Caris Life Sciences
11.4.1 Caris Life Sciences Company Information
11.4.2 Caris Life Sciences Hereditary Cancer Testing Product Offered
11.4.3 Caris Life Sciences Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Caris Life Sciences Main Business Overview
11.4.5 Caris Life Sciences Latest Developments
11.5 BioReference Laboratories (GeneDx)
11.5.1 BioReference Laboratories (GeneDx) Company Information
11.5.2 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Product Offered
11.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 BioReference Laboratories (GeneDx) Main Business Overview
11.5.5 BioReference Laboratories (GeneDx) Latest Developments
11.6 LabSolutions
11.6.1 LabSolutions Company Information
11.6.2 LabSolutions Hereditary Cancer Testing Product Offered
11.6.3 LabSolutions Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 LabSolutions Main Business Overview
11.6.5 LabSolutions Latest Developments
11.7 Progenity，Inc
11.7.1 Progenity，Inc Company Information
11.7.2 Progenity，Inc Hereditary Cancer Testing Product Offered
11.7.3 Progenity，Inc Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Progenity，Inc Main Business Overview
11.7.5 Progenity，Inc Latest Developments
11.8 ARUP Laboratories
11.8.1 ARUP Laboratories Company Information
11.8.2 ARUP Laboratories Hereditary Cancer Testing Product Offered
11.8.3 ARUP Laboratories Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 ARUP Laboratories Main Business Overview
11.8.5 ARUP Laboratories Latest Developments
11.9 Myriad
11.9.1 Myriad Company Information
11.9.2 Myriad Hereditary Cancer Testing Product Offered
11.9.3 Myriad Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Myriad Main Business Overview
11.9.5 Myriad Latest Developments
11.10 NeoGenomics
11.10.1 NeoGenomics Company Information
11.10.2 NeoGenomics Hereditary Cancer Testing Product Offered
11.10.3 NeoGenomics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 NeoGenomics Main Business Overview
11.10.5 NeoGenomics Latest Developments
11. Blueprint Genetics
11.11.1 Blueprint Genetics Company Information
11.11.2 Blueprint Genetics Hereditary Cancer Testing Product Offered
11.11.3 Blueprint Genetics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Blueprint Genetics Main Business Overview
11.11.5 Blueprint Genetics Latest Developments
11.12 CellMax Life
11.12.1 CellMax Life Company Information
11.12.2 CellMax Life Hereditary Cancer Testing Product Offered
11.12.3 CellMax Life Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 CellMax Life Main Business Overview
11.12.5 CellMax Life Latest Developments
11.13 Fulgent Genetics
11.13.1 Fulgent Genetics Company Information
11.13.2 Fulgent Genetics Hereditary Cancer Testing Product Offered
11.13.3 Fulgent Genetics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Fulgent Genetics Main Business Overview
11.13.5 Fulgent Genetics Latest Developments
11.14 Strand Life Sciences
11.14.1 Strand Life Sciences Company Information
11.14.2 Strand Life Sciences Hereditary Cancer Testing Product Offered
11.14.3 Strand Life Sciences Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Strand Life Sciences Main Business Overview
11.14.5 Strand Life Sciences Latest Developments
11.15 Myogenes
11.15.1 Myogenes Company Information
11.15.2 Myogenes Hereditary Cancer Testing Product Offered
11.15.3 Myogenes Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Myogenes Main Business Overview
11.15.5 Myogenes Latest Developments
11.16 LabCorp
11.16.1 LabCorp Company Information
11.16.2 LabCorp Hereditary Cancer Testing Product Offered
11.16.3 LabCorp Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 LabCorp Main Business Overview
11.16.5 LabCorp Latest Developments
11.17 Quest Diagnostics
11.17.1 Quest Diagnostics Company Information
11.17.2 Quest Diagnostics Hereditary Cancer Testing Product Offered
11.17.3 Quest Diagnostics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 Quest Diagnostics Main Business Overview
11.17.5 Quest Diagnostics Latest Developments
11.18 Pathway Genomics
11.18.1 Pathway Genomics Company Information
11.18.2 Pathway Genomics Hereditary Cancer Testing Product Offered
11.18.3 Pathway Genomics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2019-2021)
11.18.4 Pathway Genomics Main Business Overview
11.18.5 Pathway Genomics Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Hereditary Cancer Testing Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of RNA Testing
Table 3. Major Players of DNA Testing
Table 4. Hereditary Cancer Testing Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 5. Global Hereditary Cancer Testing Market Size by Type (2016-2021) & ($ Millions)
Table 6. Global Hereditary Cancer Testing Market Size Market Share by Type (2016-2021)
Table 7. Hereditary Cancer Testing Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 8. Global Hereditary Cancer Testing Market Size by Application (2016-2021) & ($ Millions)
Table 9. Global Hereditary Cancer Testing Market Size Market Share by Application (2016-2021)
Table 10. Global Hereditary Cancer Testing Revenue by Players (2019-2021E) & ($ Millions)
Table 11. Global Hereditary Cancer Testing Revenue Market Share by Players (2019-2021E)
Table 12. Hereditary Cancer Testing Key Players Head office and Products Offered
Table 13. Hereditary Cancer Testing Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Hereditary Cancer Testing Market Size by Regions 2016-2021 & ($ Millions)
Table 17. Global Hereditary Cancer Testing Market Size Market Share by Regions 2016-2021
Table 18. Americas Hereditary Cancer Testing Market Size by Country (2016-2021) & ($ Millions)
Table 19. Americas Hereditary Cancer Testing Market Size Market Share by Country (2016-2021)
Table 20. Americas Hereditary Cancer Testing Market Size by Type (2016-2021) & ($ Millions)
Table 21. Americas Hereditary Cancer Testing Market Size Market Share by Type (2016-2021)
Table 22. Americas Hereditary Cancer Testing Market Size by Application (2016-2021) & ($ Millions)
Table 23. Americas Hereditary Cancer Testing Market Size Market Share by Application (2016-2021)
Table 24. APAC Hereditary Cancer Testing Market Size by Region (2016-2021) & ($ Millions)
Table 25. APAC Hereditary Cancer Testing Market Size Market Share by Region (2016-2021)
Table 26. APAC Hereditary Cancer Testing Market Size by Type (2016-2021) & ($ Millions)
Table 27. APAC Hereditary Cancer Testing Market Size Market Share by Type (2016-2021)
Table 28. APAC Hereditary Cancer Testing Market Size by Application (2016-2021) & ($ Millions)
Table 29. APAC Hereditary Cancer Testing Market Size Market Share by Application (2016-2021)
Table 30. Europe Hereditary Cancer Testing Market Size by Country (2016-2021) & ($ Millions)
Table 31. Europe Hereditary Cancer Testing Market Size Market Share by Country (2016-2021)
Table 32. Europe Hereditary Cancer Testing Market Size by Type (2016-2021) & ($ Millions)
Table 33. Europe Hereditary Cancer Testing Market Size Market Share by Type (2016-2021)
Table 34. Europe Hereditary Cancer Testing Market Size by Application (2016-2021) & ($ Millions)
Table 35. Europe Hereditary Cancer Testing Market Size Market Share by Application (2016-2021)
Table 36. Middle East & Africa Hereditary Cancer Testing Market Size by Region (2016-2021) & ($ Millions)
Table 37. Middle East & Africa Hereditary Cancer Testing Market Size Market Share by Region (2016-2021)
Table 38. Middle East & Africa Hereditary Cancer Testing Market Size by Type (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Hereditary Cancer Testing Market Size Market Share by Type (2016-2021)
Table 40. Middle East & Africa Hereditary Cancer Testing Market Size by Application (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Hereditary Cancer Testing Market Size Market Share by Application (2016-2021)
Table 42. Key and Potential Regions of Hereditary Cancer Testing
Table 43. Key Application and Potential Industries of Hereditary Cancer Testing
Table 44. Key Challenges of Hereditary Cancer Testing
Table 45. Key Trends of Hereditary Cancer Testing
Table 46. Global Hereditary Cancer Testing Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 47. Global Hereditary Cancer Testing Market Size Market Share Forecast by Regions (2021-2026)
Table 48. Global Hereditary Cancer Testing Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 49. Global Hereditary Cancer Testing Market Size Market Share Forecast by Type (2021-2026)
Table 50. Global Hereditary Cancer Testing Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 51. Global Hereditary Cancer Testing Market Size Market Share Forecast by Application (2021-2026)
Table 52. Ambry Genetics (Konica Minota) Details, Company Type, Hereditary Cancer Testing Area Served and Its Competitors
Table 53. Ambry Genetics (Konica Minota) Hereditary Cancer Testing Product Offered
Table 54. Ambry Genetics (Konica Minota) Hereditary Cancer Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 55. Ambry Genetics (Konica Minota) Main Business
Table 56. Ambry Genetics (Konica Minota) Latest Developments
Table 57. Asper Biogene Details, Company Type, Hereditary Cancer Testing Area Served and Its Competitors
Table 58. Asper Biogene Hereditary Cancer Testing Product Offered
Table 59. Asper Biogene Main Business
Table 60. Asper Biogene Hereditary Cancer Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 61. Asper Biogene Latest Developments
Table 62. Natera Details, Company Type, Hereditary Cancer Testing Area Served and Its Competitors
Table 63. Natera Hereditary Cancer Testing Product Offered
Table 64. Natera Main Business
Table 65. Natera Hereditary Cancer Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. Natera Latest Developments
Table 67. Caris Life Sciences Details, Company Type, Hereditary Cancer Testing Area Served and Its Competitors
Table 68. Caris Life Sciences Hereditary Cancer Testing Product Offered
Table 69. Caris Life Sciences Main Business
Table 70. Caris Life Sciences Hereditary Cancer Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. Caris Life Sciences Latest Developments
Table 72. BioReference Laboratories (GeneDx) Details, Company Type, Hereditary Cancer Testing Area Served and Its Competitors
Table 73. BioReference Laboratories (GeneDx) Hereditary Cancer Testing Product Offered
Table 74. BioReference Laboratories (GeneDx) Main Business
Table 75. BioReference Laboratories (GeneDx) Hereditary Cancer Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. BioReference Laboratories (GeneDx) Latest Developments
Table 77. LabSolutions Details, Company Type, Hereditary Cancer Testing Area Served and Its Competitors
Table 78. LabSolutions Hereditary Cancer Testing Product Offered
Table 79. LabSolutions Main Business
Table 80. LabSolutions Hereditary Cancer Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. LabSolutions Latest Developments
Table 82. Progenity，Inc Details, Company Type, Hereditary Cancer Testing Area Served and Its Competitors
Table 83. Progenity，Inc Hereditary Cancer Testing Product Offered
Table 84. Progenity，Inc Main Business
Table 85. Progenity，Inc Hereditary Cancer Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 86. Progenity，Inc Latest Developments
Table 87. ARUP Laboratories Details, Company Type, Hereditary Cancer Testing Area Served and Its Competitors
Table 88. ARUP Laboratories Hereditary Cancer Testing Product Offered
Table 89. ARUP Laboratories Main Business
Table 90. ARUP Laboratories Hereditary Cancer Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 91. ARUP Laboratories Latest Developments
Table 92. Myriad Details, Company Type, Hereditary Cancer Testing Area Served and Its Competitors
Table 93. Myriad Hereditary Cancer Testing Product Offered
Table 94. Myriad Main Business
Table 95. Myriad Hereditary Cancer Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 96. Myriad Latest Developments
Table 97. NeoGenomics Details, Company Type, Hereditary Cancer Testing Area Served and Its Competitors
Table 98. NeoGenomics Hereditary Cancer Testing Product Offered
Table 99. NeoGenomics Main Business
Table 100. NeoGenomics Hereditary Cancer Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 101. NeoGenomics Latest Developments
Table 102. Blueprint Genetics Details, Company Type, Hereditary Cancer Testing Area Served and Its Competitors
Table 103. Blueprint Genetics Hereditary Cancer Testing Product Offered
Table 104. Blueprint Genetics Hereditary Cancer Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 105. Blueprint Genetics Main Business
Table 106. Blueprint Genetics Latest Developments
Table 107. CellMax Life Details, Company Type, Hereditary Cancer Testing Area Served and Its Competitors
Table 108. CellMax Life Hereditary Cancer Testing Product Offered
Table 109. CellMax Life Main Business
Table 110. CellMax Life Hereditary Cancer Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 111. CellMax Life Latest Developments
Table 112. Fulgent Genetics Details, Company Type, Hereditary Cancer Testing Area Served and Its Competitors
Table 113. Fulgent Genetics Hereditary Cancer Testing Product Offered
Table 114. Fulgent Genetics Main Business
Table 115. Fulgent Genetics Hereditary Cancer Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 116. Fulgent Genetics Latest Developments
Table 117. Strand Life Sciences Details, Company Type, Hereditary Cancer Testing Area Served and Its Competitors
Table 118. Strand Life Sciences Hereditary Cancer Testing Product Offered
Table 119. Strand Life Sciences Main Business
Table 120. Strand Life Sciences Hereditary Cancer Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 121. Strand Life Sciences Latest Developments
Table 122. Myogenes Details, Company Type, Hereditary Cancer Testing Area Served and Its Competitors
Table 123. Myogenes Hereditary Cancer Testing Product Offered
Table 124. Myogenes Main Business
Table 125. Myogenes Hereditary Cancer Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 126. Myogenes Latest Developments
Table 127. LabCorp Details, Company Type, Hereditary Cancer Testing Area Served and Its Competitors
Table 128. LabCorp Hereditary Cancer Testing Product Offered
Table 129. LabCorp Main Business
Table 130. LabCorp Hereditary Cancer Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 131. LabCorp Latest Developments
Table 132. Quest Diagnostics Details, Company Type, Hereditary Cancer Testing Area Served and Its Competitors
Table 133. Quest Diagnostics Hereditary Cancer Testing Product Offered
Table 134. Quest Diagnostics Main Business
Table 135. Quest Diagnostics Hereditary Cancer Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 136. Quest Diagnostics Latest Developments
Table 137. Pathway Genomics Details, Company Type, Hereditary Cancer Testing Area Served and Its Competitors
Table 138. Pathway Genomics Hereditary Cancer Testing Product Offered
Table 139. Pathway Genomics Main Business
Table 140. Pathway Genomics Hereditary Cancer Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 141. Pathway Genomics Latest Developments
List of Figures
Figure 1. Hereditary Cancer Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hereditary Cancer Testing Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Hereditary Cancer Testing Market Size Market Share by Type in 2020
Figure 7. Hereditary Cancer Testing in Breast Cancer
Figure 8. Global Hereditary Cancer Testing Market: Breast Cancer (2016-2021) & ($ Millions)
Figure 9. Hereditary Cancer Testing in Gastrointestinal Cancer
Figure 10. Global Hereditary Cancer Testing Market: Gastrointestinal Cancer (2016-2021) & ($ Millions)
Figure 11. Hereditary Cancer Testing in Prostate Cancer
Figure 12. Global Hereditary Cancer Testing Market: Prostate Cancer (2016-2021) & ($ Millions)
Figure 13. Hereditary Cancer Testing in Respiratory/Lung Cancer
Figure 14. Global Hereditary Cancer Testing Market: Respiratory/Lung Cancer (2016-2021) & ($ Millions)
Figure 15. Hereditary Cancer Testing in Other Cancers
Figure 16. Global Hereditary Cancer Testing Market: Other Cancers (2016-2021) & ($ Millions)
Figure 17. Global Hereditary Cancer Testing Market Size Market Share by Application in 2020
Figure 18. Global Hereditary Cancer Testing Revenue Market Share by Player in 2020
Figure 19. Global Hereditary Cancer Testing Market Size Market Share by Regions (2016-2021)
Figure 20. Americas Hereditary Cancer Testing Market Size 2016-2021 ($ Millions)
Figure 21. APAC Hereditary Cancer Testing Market Size 2016-2021 ($ Millions)
Figure 22. Europe Hereditary Cancer Testing Market Size 2016-2021 ($ Millions)
Figure 23. Middle East & Africa Hereditary Cancer Testing Market Size 2016-2021 ($ Millions)
Figure 24. Americas Hereditary Cancer Testing Market Size Market Share by Country in 2020
Figure 25. Americas Hereditary Cancer Testing Market Size Market Share by Type in 2020
Figure 26. Americas Hereditary Cancer Testing Market Size Market Share by Application in 2020
Figure 27. United States Hereditary Cancer Testing Market Size Growth 2016-2021 ($ Millions)
Figure 28. Canada Hereditary Cancer Testing Market Size Growth 2016-2021 ($ Millions)
Figure 29. Mexico Hereditary Cancer Testing Market Size Growth 2016-2021 ($ Millions)
Figure 30. APAC Hereditary Cancer Testing Market Size Market Share by Regions in 2020
Figure 31. APAC Hereditary Cancer Testing Market Size Market Share by Type in 2020
Figure 32. APAC Hereditary Cancer Testing Market Size Market Share by Application in 2020
Figure 33. China Hereditary Cancer Testing Market Size Growth 2016-2021 ($ Millions)
Figure 34. Japan Hereditary Cancer Testing Market Size Growth 2016-2021 ($ Millions)
Figure 35. Korea Hereditary Cancer Testing Market Size Growth 2016-2021 ($ Millions)
Figure 36. Southeast Asia Hereditary Cancer Testing Market Size Growth 2016-2021 ($ Millions)
Figure 37. India Hereditary Cancer Testing Market Size Growth 2016-2021 ($ Millions)
Figure 38. Australia Hereditary Cancer Testing Market Size Growth 2016-2021 ($ Millions)
Figure 39. Europe Hereditary Cancer Testing Market Size Market Share by Country in 2020
Figure 40. Europe Hereditary Cancer Testing Market Size Market Share by Type in 2020
Figure 41. Europe Hereditary Cancer Testing Market Size Market Share by Application in 2020
Figure 42. Germany Hereditary Cancer Testing Market Size Growth 2016-2021 ($ Millions)
Figure 43. France Hereditary Cancer Testing Market Size Growth 2016-2021 ($ Millions)
Figure 44. UK Hereditary Cancer Testing Market Size Growth 2016-2021 ($ Millions)
Figure 45. Italy Hereditary Cancer Testing Market Size Growth 2016-2021 ($ Millions)
Figure 46. Russia Hereditary Cancer Testing Market Size Growth 2016-2021 ($ Millions)
Figure 47. Middle East & Africa Hereditary Cancer Testing Market Size Market Share by Region in 2020
Figure 48. Middle East & Africa Hereditary Cancer Testing Market Size Market Share by Type in 2020
Figure 49. Middle East & Africa Hereditary Cancer Testing Market Size Market Share by Application in 2020
Figure 50. Egypt Hereditary Cancer Testing Market Size Growth 2016-2021 ($ Millions)
Figure 51. South Africa Hereditary Cancer Testing Market Size Growth 2016-2021 ($ Millions)
Figure 52. Israel Hereditary Cancer Testing Market Size Growth 2016-2021 ($ Millions)
Figure 53. Turkey Hereditary Cancer Testing Market Size Growth 2016-2021 ($ Millions)
Figure 54. GCC Country Hereditary Cancer Testing Market Size Growth 2016-2021 ($ Millions)
Figure 55. Americas Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 56. APAC Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 57. Europe Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 58. Middle East & Africa Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 59. United States Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 60. Canada Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 61. Mexico Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 62. Brazil Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 63. China Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 64. Japan Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 65. Korea Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 66. Southeast Asia Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 67. India Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 68. Australia Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 69. Germany Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 70. France Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 71. UK Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 72. Italy Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 73. Russia Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 74. Spain Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 75. Egypt Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 76. South Africa Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 77. Israel Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 78. Turkey Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)
Figure 79. GCC Country Hereditary Cancer Testing Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 유전성 암 검사 시장예측 2021년-2026년] (코드 : LPI-2201K00125) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 유전성 암 검사 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 흑색종 피부암 진단 검사 시장예측 2021년-2026년
LPI-2201K03867 / LP Information / 2021년 12월 / 본 조사보고서는 흑색종 피부암 진단 검사의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Melanoma Skin Cancer Diagnostic Testing will have significant change from previous year. By the most conservative estimates of global Melanoma Skin Cancer Diagnostic Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from...

세계의 유전성 혈관부종 시장예측 2021년-2026년
LPI-2201K00039 / LP Information / 2021년 12월 / 본 조사보고서는 유전성 혈관부종의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Hereditary Angioedema will have significant change from previous year. By the most conservative estimates of global Hereditary Angioedema market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1620.7 million in 2020. Over...

세계의 HPV 검사 시장예측 2021년-2026년
LPI-2201K00134 / LP Information / 2021년 12월 / 본 조사보고서는 HPV 검사의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of HPV Testing will have significant change from previous year. By the most conservative estimates of global HPV Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 724.9 million in 2020. Over...

세계의 호르몬 불응성 전립선암 시장예측 2021년-2026년
LPI-2201K00131 / LP Information / 2021년 12월 / 본 조사보고서는 호르몬 불응성 전립선암의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Hormone Refractory Prostate Cancer will have significant change from previous year. By the most conservative estimates of global Hormone Refractory Prostate Cancer market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 mRNA 암 백신 및 치료제 시장예측 2021년-2026년
LPI-2201K02233 / LP Information / 2021년 12월 / 본 조사보고서는 mRNA 암 백신 및 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of mRNA Cancer Vaccines and Therapeutics will have significant change from previous year. By the most conservative estimates of global mRNA Cancer Vaccines and Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from...

세계의 두경부암 치료제 시장예측 2021년-2026년
LPI-2201K00107 / LP Information / 2021년 12월 / 본 조사보고서는 두경부암 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Head and Neck Cancer Therapeutics will have significant change from previous year. By the most conservative estimates of global Head and Neck Cancer Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from...

세계의 전이성 암 치료 시장예측 2021년-2026년
LPI-2201K02228 / LP Information / 2021년 12월 / 본 조사보고서는 전이성 암 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Metastatic Cancer Treatment will have significant change from previous year. By the most conservative estimates of global Metastatic Cancer Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 49140 million in...